These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 16826582)
1. Prognostic role of p27Kip1 deregulation in colorectal cancer. Hershko DD; Shapira M Cancer; 2006 Aug; 107(4):668-75. PubMed ID: 16826582 [TBL] [Abstract][Full Text] [Related]
2. The prognostic impact of the ubiquitin ligase subunits Skp2 and Cks1 in colorectal carcinoma. Shapira M; Ben-Izhak O; Linn S; Futerman B; Minkov I; Hershko DD Cancer; 2005 Apr; 103(7):1336-46. PubMed ID: 15717322 [TBL] [Abstract][Full Text] [Related]
3. Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer. Hershko DD Cancer; 2008 Apr; 112(7):1415-24. PubMed ID: 18260093 [TBL] [Abstract][Full Text] [Related]
4. Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study. Liu Z; Fu Q; Lv J; Wang F; Ding K J Exp Clin Cancer Res; 2008 Oct; 27(1):51. PubMed ID: 18922157 [TBL] [Abstract][Full Text] [Related]
5. Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma. Shapira M; Ben-Izhak O; Bishara B; Futerman B; Minkov I; Krausz MM; Pagano M; Hershko DD Cancer; 2004 Apr; 100(8):1615-21. PubMed ID: 15073847 [TBL] [Abstract][Full Text] [Related]
6. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas. Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491 [TBL] [Abstract][Full Text] [Related]
7. Mutant B-RAF signaling and cyclin D1 regulate Cks1/S-phase kinase-associated protein 2-mediated degradation of p27Kip1 in human melanoma cells. Bhatt KV; Hu R; Spofford LS; Aplin AE Oncogene; 2007 Feb; 26(7):1056-66. PubMed ID: 16924241 [TBL] [Abstract][Full Text] [Related]
8. The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer. Bochis OV; Irimie A; Pichler M; Berindan-Neagoe I J Gastrointestin Liver Dis; 2015 Jun; 24(2):225-34. PubMed ID: 26114183 [TBL] [Abstract][Full Text] [Related]
9. Bortezomib (Velcade) induces p27Kip1 expression through S-phase kinase protein 2 degradation in colorectal cancer. Uddin S; Ahmed M; Bavi P; El-Sayed R; Al-Sanea N; AbdulJabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Hussain AR; Al-Kuraya KS Cancer Res; 2008 May; 68(9):3379-88. PubMed ID: 18451165 [TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of Skp2 and p27 in human breast cancer. Traub F; Mengel M; Lück HJ; Kreipe HH; von Wasielewski R Breast Cancer Res Treat; 2006 Sep; 99(2):185-91. PubMed ID: 16636894 [TBL] [Abstract][Full Text] [Related]
11. Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship. Li Q; Murphy M; Ross J; Sheehan C; Carlson JA J Cutan Pathol; 2004 Nov; 31(10):633-42. PubMed ID: 15491322 [TBL] [Abstract][Full Text] [Related]
12. Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer. Ben-Izhak O; Lahav-Baratz S; Meretyk S; Ben-Eliezer S; Sabo E; Dirnfeld M; Cohen S; Ciechanover A J Urol; 2003 Jul; 170(1):241-5. PubMed ID: 12796697 [TBL] [Abstract][Full Text] [Related]
13. p27Kip1 is inactivated in human colorectal cancer by cytoplasmic localization associated with activation of Akt/PKB. Bottini C; Platini F; Rinaldi M; Leutner M; Alabiso O; Garavoglia M; Tessitore L Int J Oncol; 2009 Jan; 34(1):69-77. PubMed ID: 19082479 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas. Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576 [TBL] [Abstract][Full Text] [Related]
15. Cyclin-dependent kinase 1 gene expression is associated with poor prognosis in gastric carcinoma. Masuda TA; Inoue H; Nishida K; Sonoda H; Yoshikawa Y; Kakeji Y; Utsunomiya T; Mori M Clin Cancer Res; 2003 Nov; 9(15):5693-8. PubMed ID: 14654553 [TBL] [Abstract][Full Text] [Related]
16. Expression of the ubiquitin ligase subunit cyclin kinase subunit 1 and its relationship to S-phase kinase protein 2 and p27Kip1 in prostate cancer. Shapira M; Ben-Izhak O; Slotky M; Goldin O; Lahav-Baratz S; Hershko DD J Urol; 2006 Nov; 176(5):2285-9. PubMed ID: 17070313 [TBL] [Abstract][Full Text] [Related]
17. CKS1B overexpression implicates clinical aggressiveness of hepatocellular carcinomas but not p27(Kip1) protein turnover: an independent prognosticator with potential p27 (Kip1)-independent oncogenic attributes? Huang CW; Lin CY; Huang HY; Liu HW; Chen YJ; Shih DF; Chen HY; Juan CC; Ker CG; Huang CY; Li CF; Shiue YL Ann Surg Oncol; 2010 Mar; 17(3):907-22. PubMed ID: 19866239 [TBL] [Abstract][Full Text] [Related]
18. The expression of the ubiquitin ligase subunit Cks1 in human breast cancer. Slotky M; Shapira M; Ben-Izhak O; Linn S; Futerman B; Tsalic M; Hershko DD Breast Cancer Res; 2005; 7(5):R737-44. PubMed ID: 16168119 [TBL] [Abstract][Full Text] [Related]
19. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression. Halfter H; Friedrich M; Resch A; Kullmann M; Stögbauer F; Ringelstein EB; Hengst L Cancer Res; 2006 Jul; 66(13):6530-9. PubMed ID: 16818624 [TBL] [Abstract][Full Text] [Related]
20. Increased SKP2 and CKS1 gene expression contributes to the progression of human urothelial carcinoma. Kawakami K; Enokida H; Tachiwada T; Nishiyama K; Seki N; Nakagawa M J Urol; 2007 Jul; 178(1):301-7. PubMed ID: 17499794 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]